Showing results (41-50 of 4,765) with videos related to
Sort By:
Pageof 477
Archives of Neurology|November 1, 1993
The role of neurogenetics in Gaucher diseaseR O Brady, N W Barton, G A GrabowskiHuman Molecular Genetics|August 13, 1998
Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storageH Du, M Duanmu, D Witte, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|September 1, 1982
Gaucher type I (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrateG A Grabowski, T Dinur, S Gatt, et al.Archives of Biochemistry and Biophysics|May 15, 1984
Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sitesG A Grabowski, S Gatt, J Kruse, et al.American Journal of Human Genetics|August 1, 1989
Gaucher disease: molecular heterogeneity and phenotype-genotype correlationsB Theophilus, T Latham, G A Grabowski, et al.Molecular Genetics and Metabolism|December 26, 2001
Temporal and spatial expression of murine acid beta-glucosidase mRNAE Ponce, D P Witte, A Hung, et al.Analytical Biochemistry|January 1, 1984
Synthesis of a fluorescent derivative of glucosyl ceramide for the sensitive determination of glucocerebrosidase activityT Dinur, G A Grabowski, R J Desnick, et al.American Journal of Medical Genetics|July 11, 1997
Gaucher disease: enzyme therapy in the acute neuronopathic variantC A Prows, N Sanchez, C Daugherty, et al.Clinical Genetics|February 21, 2007
The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher diseaseJ Charrow, B Dulisse, G A Grabowski, et al.American Journal of Surgery|January 11, 1991
A 27-year experience with splenectomy for Gaucher's diseaseP R Fleshner, A H Aufses, G A Grabowski, et al.Pageof 477